Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TriMemo™ SEMIRIGID ANNULOPLASTY RING

K-Number: K260498 · 2026-04-14

ApplicantCorcym S.r.l.
Decision Date2026-04-14
Product CodeKRH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TriMemo™ SEMIRIGID ANNULOPLASTY RING is a medical device manufactured by Corcym S.r.l.. It received FDA 510(k) clearance on 2026-04-14 under approval number K260498. The device is classified under product code KRH. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TriMemo™ SEMIRIGID ANNULOPLASTY RING?

TriMemo™ SEMIRIGID ANNULOPLASTY RING is a medical device that received FDA 510(k) clearance on 2026-04-14. It is manufactured by Corcym S.r.l.. The 510(k) number is K260498.

When was TriMemo™ SEMIRIGID ANNULOPLASTY RING approved by the FDA?

TriMemo™ SEMIRIGID ANNULOPLASTY RING received FDA 510(k) clearance on 2026-04-14, under approval number K260498.

What company makes TriMemo™ SEMIRIGID ANNULOPLASTY RING?

TriMemo™ SEMIRIGID ANNULOPLASTY RING is manufactured by Corcym S.r.l..

What is the FDA product code for TriMemo™ SEMIRIGID ANNULOPLASTY RING?

The FDA product code for TriMemo™ SEMIRIGID ANNULOPLASTY RING is KRH.

Other Devices by Corcym S.r.l.

Related Devices (Code: KRH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.